Search
Search Results
##search.searchResults.foundPlural##
-
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2438PDF: 1297HTML: 1746CoverLetter: 178 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1094PDF: 541HTML: 1689Figures: 165Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1514PDF: 936HTML: 222 -
WHAT ARE FUNGAL INFECTIONS?
4163PDF: 2369HTML: 27593de Pauw: 235 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2794PDF: 1004HTML: 5518 -
Acquired Hemophilia A successfully treated with rituximab
1927PDF: 1142HTML: 1456Figure 1: 174 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1384PDF: 685HTML: 1079Untitled: 179Untitled: 149Untitled: 130Untitled: 151Untitled: 161 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1771PDF: 698HTML: 335 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7418PDF: 2414HTML: 1726Table 1.: 207Table 2.: 216Table 3.: 200Table 4.: 199 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1699PDF: 762HTML: 496 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2248PDF: 931HTML: 300 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2317PDF: 982HTML: 7622Untitled: 273Fig2: 183Fig3: 166Fig4: 179 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9039PDF: 6048HTML: 87947Fig.1b: 183Fig.1c: 187Fig.2a: 175Fig.2b: 174Fig.4: 188Fig.2c: 182Fig.3: 179Tab.1: 225Tab.2: 206Tab.3: 188Tab.4: 220Fig1a: 180 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1287PDF: 563Suppl. Files: 343HTML: 141 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2062PDF: 1114HTML: 7690cover letter paper final AML: 213 -
CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates
1942PDF: 1128HTML: 249 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3990PDF: 1048HTML: 3588Untitled: 175Cneo. Fig.1: 112Untitled: 103Untitled: 126Untitled: 130 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2043PDF: 1859HTML: 343 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3220PDF: 1004HTML: 2023 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1601PDF: 804HTML: 161 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1753PDF: 565HTML: 278 -
-
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1183PDF: 1060HTML: 198 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3260PDF: 1235HTML: 8103 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1648PDF: 1171HTML: 199 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7924PDF: 4102HTML: 7358







